The FDA recently announced it is renewing its contract with Waterloo University to conduct a cannabis study. Since 2019, the FDA and the University have conducted International Cannabis Policy Study (ICPS).

According to a recent study published in the Psychological Medicine Journal, cannabis legalization has not led to an increase in substance use disorders or increased use of other illicit drugs, and “should not be considered a ‘gateway drug.’”